期刊文献+

不同中医证型维吾尔族溃疡性结肠炎患者血清趋化因子水平的研究

Uighur different syndromes in patients with ulcrative colitis chemokine levels in
下载PDF
导出
摘要 目的:探讨不同中医证型维吾尔族溃疡性结肠炎患者血清趋化因子白介素-8(IL-8)及单核细胞趋化蛋白-1(MCP-1)水平的变化与结肠组织过氧化物酶(MPO)的相关性,以及其临床意义,为临床辨证提供客观化指标。方法:采用ELISA法检测70例不同中医证型维吾尔族溃疡性结肠炎患者血清白介素-8(IL-8)及单核细胞趋化蛋白-1(MCP-1)水平;结肠组织MPO含量采用生化方法检测,同时观察IL-8及MCP-1水平与结肠组织MPO含量的关系。结果:不同中医证型维吾尔族溃疡性结肠炎患者IL-8及MCP-1水平,结肠组织MPO含量均高于正常对照(P<0.05);血清IL-8、MCP-1水平与患者MPO含量呈正相关(r=0.7535、0.8266、0.7638;P<0.05)。结论:维吾尔族UC患者中趋化因子IL-8及MCP-1可能参与了溃疡性结肠炎炎症损伤过程,血清IL-8及MCP-1水平增高可以做为湿热内蕴证和气滞血瘀证的客观化指标。 Objective: To explore the different syndromes in patients with ulcerative colitis Uygur chemokine interleukin -8 (IL-8) and monocyte chemoattractant protein -1 (MCP-1) levels in patients with colon myeloperoxidase (MPO) of relevance, and its clinical signifi- cance, as the clinical syndrome to provide objective metrics. Methods: The ELISA method detected 70 cases of different syndromes in patients with ulcerative colitis Uighur Interleukin -8 (IL-8) and monocyte chemoattractant protein -1 (MCP-1) levels; colon MPO levels detected by biochemical methods, while observing the IL-8 and MCP-1 levels and the relationship between colon tissue MPO content. Resuits: (1) Uighur different syndromes in patients with ulcerative colitis in IL-8 and MCP-1 levels, colon tissue MPO levels were higher than normal controls (P〈0.05); serum IL-8, MCP-1 levels in patients MPO levels were positively correlated (r = 0.7535, 0.8266, 0.7638; P〈0.05).Conclusion: UC patients chemokine IL-8 and MCP-1 may be involved in the inflammation of ulcerative colitis injury, serum IL-8 and MCP-1 levels can increase as evidence of dampness and Qi stagnation objective evidence of indicators.
作者 吴芳 曾斌芳
出处 《内蒙古中医药》 2010年第21期61-62,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 溃疡性结肠炎 中医证型 趋化因子 白介素-8 单核细胞趋化蛋白-1 Ulcerative colitis TCM syndrome chemotactic factor Interleukin -8 monocyte chemoattractant protein -1
  • 相关文献

参考文献9

  • 1MacDonald IT,Monteleone G,Pender SL.Recent developments in the immunology of inflammatory bowel disease[J].Scand J Immunol,2003,51:2-9.
  • 2Lakatos L.Immunology of inflammatory bowel diseases[JJ.Acta Physiol Hung,2005,87:355-372.
  • 3Ogata H,Hibi T.Cytokine and anti-cytokine therapies for inflammatory bowel disease[J].Curr Pharm Des,2003,9:1107-1113.
  • 4韩英,李世荣.黏膜免疫与炎症性肠病[J].中华内科杂志,2003,42(6):444-445. 被引量:5
  • 5刘健,张赣生,王根生.细胞免疫指标与溃疡性结肠炎严重程度的关系[J].胃肠病学,2003,8(3):159-161. 被引量:7
  • 6祁虹,马红.溃疡性结肠炎患者外周血 T 细胞亚群和免疫球蛋白分析[J].辽宁医学杂志,1997,11(2):85-86. 被引量:9
  • 7中华医学会消化病学分会.对炎症性肠病诊断治疗规范的建议.中华消化杂志,2005,21:236-369.
  • 8Odorico A.Bortolan S,Cardin R.Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease[J] Scand J Gastroenterol,2003,31:1289-1294.
  • 9Johansson M,Norrgard O,Forsgren S.Study of expression patterns and levels of neurotrophins and neurotrophin receptors in ul-cerative colitis[J].Inflamm Bowel Dis,2007,13:398-409.

二级参考文献8

  • 1蒋维国,徐华.溃疡性结肠炎患者外周血T淋巴细胞亚群检测及其意义[J].中国肛肠病杂志,1997,17(1):6-7. 被引量:17
  • 2八尾恒良 见:小俣政男 杉本桓明主编.溃疡性大肠炎[A].见:小俣政男,杉本桓明主编.内科学(朝仓书店).第6版[C].大日本印刷,.912~915.
  • 3石田博 大田博之 柳田英寿 土桥浩章.Thl介在自己免疫病とTh2介在自己免疫病[J].日本临床,1997,55:122-127.
  • 4Nielsen OH, Kirman I, Johnson K, Giedlin M,Ciardelli T. The circulating common gamma chain(CD132) in inflammatory bowel disease. Am J Gastroenterol, 1998, 93: 323--328.
  • 5Matsuura T, West GA, Klein JS, Ferraris L, Fiocchi C. Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease. Gastroenterology. 1992. 102: 2006--2014.
  • 6Rubin LA, Kurman CC, Fritz ME, Biddison WE,Boutin B, Yarchoan R, Nelson DL. Soluble inter-leukin 2 receptors are released from activated human lymphoid T-lymphocytes in vitro. J Immunol,1985, 135: 3172--3177.
  • 7Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology,2002, 122: 1592--1608.
  • 8祁虹,马红.溃疡性结肠炎患者外周血 T 细胞亚群和免疫球蛋白分析[J].辽宁医学杂志,1997,11(2):85-86. 被引量:9

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部